Suministro de Fármacos Brocopulmonar
Suministro de Fármacos Brocopulmonar
14 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058071-1410-SE22 | 29-11-2022 | Etex Farmaceutica Limitada | $4.641.000 |
| 1058071-879-SE22 | 20-07-2022 | Ethon Pharmaceuticals Ltda. | $4.305.896 |
| 1058071-541-SE22 | 05-05-2022 | Astrazeneca S.A. | $268.178 |
| 1058071-487-SE22 | 27-04-2022 | Ethon Pharmaceuticals Ltda. | $678.300 |
| 1058071-449-SE22 | 19-04-2022 | Ethon Pharmaceuticals Ltda. | $7.535.318 |
| 1058071-314-SE22 | 14-03-2022 | Astrazeneca S.A. | $357.571 |
| 1058071-290-SE22 | 09-03-2022 | Etex Farmaceutica Limitada | $368.900 |
| 1058071-168-SE22 | 08-02-2022 | Astrazeneca S.A. | $178.786 |
| 1058071-180-SE22 | 08-02-2022 | Etex Farmaceutica Limitada | $4.408.950 |
| 1058071-131-SE22 | 31-01-2022 | Ethon Pharmaceuticals Ltda. | $452.200 |
| 1058071-116-SE22 | 25-01-2022 | Etex Farmaceutica Limitada | $214.200 |
| 1058071-70-SE22 | 11-01-2022 | Etex Farmaceutica Limitada | $2.213.400 |
| 1058071-35-SE22 | 10-01-2022 | Astrazeneca S.A. | $893.928 |
| 1058071-1414-SE21 | 28-12-2021 | Etex Farmaceutica Limitada | $1.106.700 |
| 1058071-1316-SE21 | 02-12-2021 | Astrazeneca S.A. | $536.357 |
| 1058071-1211-SE21 | 02-12-2021 | Novofarma Service S.A. | $3.525.970 |
| 1058071-1213-SE21 | 26-11-2021 | Ethon Pharmaceuticals Ltda. | $5.382.370 |
| 1058071-1164-SE21 | 25-10-2021 | Novofarma Service S.A. | $2.820.776 |
| 1058071-1168-SE21 | 25-10-2021 | Socofar S.A. | $1.497.020 |
| 1058071-1169-SE21 | 22-10-2021 | Astrazeneca S.A. | $357.571 |
| 1058071-1120-SE21 | 13-10-2021 | Novofarma Service S.A. | $2.820.776 |
| 1058071-1128-SE21 | 12-10-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $312.375 |
| 1058071-1095-SE21 | 05-10-2021 | Ethon Pharmaceuticals Ltda. | $6.458.844 |
| 1058071-1044-SE21 | 21-09-2021 | Astrazeneca S.A. | $804.535 |
| 1058071-1013-SE21 | 08-09-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $357.000 |
| 1058071-994-SE21 | 06-09-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $1.231.650 |
| 1058071-999-SE21 | 06-09-2021 | Novofarma Service S.A. | $3.208.633 |
| 1058071-894-SE21 | 10-08-2021 | Etex Farmaceutica Limitada | $664.020 |
| 1058071-881-SE21 | 10-08-2021 | Novofarma Service S.A. | $2.186.101 |
| 1058071-792-SE21 | 09-07-2021 | Etex Farmaceutica Limitada | $413.168 |
| 1058071-774-SE21 | 09-07-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $3.694.950 |
| 1058071-791-SE21 | 09-07-2021 | Ethon Pharmaceuticals Ltda. | $3.035.657 |
| 1058071-759-SE21 | 07-07-2021 | Novofarma Service S.A. | $5.201.490 |
| 1058071-760-SE21 | 07-07-2021 | Novofarma Service S.A. | $4.161.192 |
| 1058071-701-SE21 | 14-06-2021 | Socofar S.A. | $5.988.080 |
| 1058071-668-SE21 | 08-06-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $3.694.950 |
| 1058071-548-SE21 | 17-05-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $2.537.199 |
| 1058071-549-SE21 | 17-05-2021 | Astrazeneca S.A. | $893.928 |
| 1058071-486-SE21 | 29-04-2021 | Astrazeneca S.A. | $446.964 |
| 1058071-416-SE21 | 12-04-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $2.019.906 |
| 1058071-408-SE21 | 09-04-2021 | Astrazeneca S.A. | $446.964 |
| 1058071-296-SE21 | 15-03-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $1.404.081 |
| 1058071-144-SE21 | 08-02-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $1.083.852 |
| 1058071-85-SE21 | 15-01-2021 | Ethon Pharmaceuticals Ltda. | $8.611.792 |
| 1058071-86-SE21 | 15-01-2021 | Etex Farmaceutica Limitada | $2.951.200 |
| 1058071-73-SE21 | 14-01-2021 | Ethon Pharmaceuticals Ltda. | $6.458.844 |
| 1058071-57-SE21 | 14-01-2021 | Glaxosmithkline Chile Farmaceutica Limitada | $4.926.600 |
| 1058071-9-SE21 | 08-01-2021 | Ethon Pharmaceuticals Ltda. | $4.305.896 |
| 1058071-1385-SE20 | 29-12-2020 | Etex Farmaceutica Limitada | $2.737.238 |
| 1058071-1382-SE20 | 22-12-2020 | Astrazeneca S.A. | $893.928 |
| 1058071-1386-SE20 | 22-12-2020 | Glaxosmithkline Chile Farmaceutica Limitada | $3.965.913 |
Fuente original:ficha mercadopublico.cl
